These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8209101)
41. How important is phosphate in the pathogenesis of renal osteodystrophy? Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572 [No Abstract] [Full Text] [Related]
42. Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. Rutherford WE; Bordier P; Marie P; Hruska K; Harter H; Greenwalt A; Blondin J; Haddad J; Bricker N; Slatopolsky E J Clin Invest; 1977 Aug; 60(2):332-41. PubMed ID: 874095 [TBL] [Abstract][Full Text] [Related]
43. Parathyroidectomy and renal insufficiency. Wilson RE Surg Annu; 1973; 5():121-43. PubMed ID: 4602212 [No Abstract] [Full Text] [Related]
44. Calcium and phosphorus metabolism in uremia and renal transplantation: an experimental model. Mitchell TS; Lee S; Gittes RF Invest Urol; 1974 Nov; 12(3):186-92. PubMed ID: 4613687 [No Abstract] [Full Text] [Related]
45. Challenges in the therapy of secondary hyperparathyroidism. Wood C; González EA; Martin KJ Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898 [TBL] [Abstract][Full Text] [Related]
50. Current issues in the management of secondary hyperparathyroidism and bone disease. Moe SM Perit Dial Int; 2001; 21 Suppl 3():S241-6. PubMed ID: 11887830 [TBL] [Abstract][Full Text] [Related]
51. Bone disease in pediatric chronic kidney disease. Wesseling-Perry K Pediatr Nephrol; 2013 Apr; 28(4):569-76. PubMed ID: 23064662 [TBL] [Abstract][Full Text] [Related]
52. [Fractures and chronic renal insufficiency]. Isaia GC; Tamone C; Ravazzoli M G Ital Nefrol; 2008; 25(1):57-65. PubMed ID: 18264919 [TBL] [Abstract][Full Text] [Related]
53. Long term results of subtotal parathyroidectomy in patients with end-stage renal disease. Kim HC; Cheigh JS; David DS; Stubenbord W; Sullivan J; Rubin AL; Stenzel KH Am Surg; 1994 Sep; 60(9):641-9. PubMed ID: 8060033 [TBL] [Abstract][Full Text] [Related]
55. [Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency]. Pérez-García R; Jofre R; Vasconez F; Caballero A; Valderrábano F Rev Clin Esp; 1982 Feb; 164(3):159-52. PubMed ID: 7089332 [No Abstract] [Full Text] [Related]
56. Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism. Sanchez CP; He YZ Kidney Int; 2007 Sep; 72(5):582-91. PubMed ID: 17554252 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of parathyroid pituitary-specific transcription factor (Pit)-1 in hyperphosphatemia-induced hyperparathyroidism of chronic renal failure rats. Jiang Y; Wang M Chin Med J (Engl); 2010 Jun; 123(12):1566-70. PubMed ID: 20819513 [TBL] [Abstract][Full Text] [Related]
58. Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism. Llach F; Massry SG; Singer FR; Kurokawa K; Kaye JH; Coburn JW J Clin Endocrinol Metab; 1975 Aug; 41(2):339-45. PubMed ID: 169280 [TBL] [Abstract][Full Text] [Related]
59. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy. Gonzalez MT; Gonzalez C; Griñó JM; Castelao AM; Mariñoso ML; Serrano S; Bonnin R; Carreras L; Alsina J Transplant Proc; 1990 Aug; 22(4):1407-11. PubMed ID: 2389341 [No Abstract] [Full Text] [Related]